Innovations in Implantable Electronics

Innovations in Implantable Electronics

  • December 2016
  • 87 pages
  • Frost & Sullivan
Report ID: 4595307
Neurostimulation and Continuous Glucose Monitoring Drive Growth Opportunities for Implantable Electronics

The technology and innovation study on implantable electronics captures active implantable medical devices used for support of debilitating function in the human body or to completely replace the function of the diseased organ. The segments covered include: cochlear implants, retinal implants, implantable continuous glucose monitoring (CGM), implantable infusion pumps, cardiovascular implantable electronic devices, and implantable neurostimulation. Recent innovations and key innovators are captured under each segment. The study also covers reimbursement scenario of each of these devices in North America, Europe and Asia-Pacific.

Regulatory framework and insurance coverage are considered to be the key factors that can lead to the successful growth of the implantable electronics market. Global patent scenario and key factors (drivers and challenges) influencing adoption have been identified. To aid C-level executives in strategic planning, technology convergence and growth opportunities (based on varied criteria such as business models and new capabilities) are captured in the study.
Industry=PatientMonitoring ParentIndustry=MedicalDevice Date=201612 Topic=MarketReport Publisher=Frost&Sullivan Price=5000